Long‐term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: Subgroup analyses of an open‐label, phase 3 study (UNCOVER‐J)

Journal of the European Academy of Dermatology and Venereology, Volume 0, Issue ja, -Not available-.